Medical Disclaimer: This content is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any health-related decisions. If you are experiencing a medical emergency, call your local emergency services immediately.
What This Page Explains
Urolithin A is a postbiotic — a compound produced by gut bacteria as a byproduct of metabolising dietary precursors. It is not found directly in any food. The pathway begins when you consume ellagitannin-rich foods such as pomegranates, walnuts, raspberries, and certain berries. These ellagitannins travel through the stomach and small intestine largely intact, reaching the colon where specific gut bacteria — primarily from the Gordonibacter, Ellagibacter, and Enterocloster genera — break them down first into ellagic acid, then through a series of transformations into urolithin A, which is absorbed into the bloodstream and distributed to tissues throughout the body. The critical issue: this bacterial conversion requires very specific gut microbes that are absent or insufficient in approximately 60% of the adult population. This is why direct supplementation with urolithin A has become the focus of clinical research — it bypasses the gut microbiome bottleneck entirely.
The Science on This Page Points to One Conclusion
Your cells need targeted support — not more vitamins, not more caffeine, not more wishful thinking. Real compounds for real cellular mechanisms.
Detailed Evidence
THE ELLAGITANNIN-TO-UROLITHIN A PATHWAY Step 1: Dietary ellagitannins (such as punicalagins from pomegranate) are consumed. These are large polyphenolic molecules that resist breakdown in the stomach and upper intestine. Step 2: Ellagitannins reach the colon intact, where they are hydrolysed and released as ellagic acid by gut microbiota. Step 3: Specific bacterial genera — Gordonibacter, Ellagibacter, and Enterocloster (formerly Clostridium) — perform a series of decarboxylation and dehydroxylation reactions, converting ellagic acid through intermediate urolithins (urolithin M5, urolithin D, urolithin C, urolithin A) into the final absorbable product. Step 4: Urolithin A is absorbed through the colonic epithelium into the portal bloodstream, undergoes phase II conjugation (glucuronidation) in the liver, and is distributed to tissues including muscle, brain, and heart. UROLITHIN METABOTYPES Humans are classified into three urolithin metabotypes (UM) based on their gut bacterial capacity to produce urolithins: - UM-A (approximately 40% of adults): efficient producers of urolithin A. - UM-B (approximately 40%): produce a mix of urolithins with lower conversion efficiency to urolithin A. - UM-0 (approximately 20%): cannot produce urolithins at all regardless of ellagitannin intake. This means roughly 60% of the population are suboptimal or non-producers of urolithin A from dietary sources alone. WHY DIET IS UNRELIABLE A 2021 study found that only 12% of subjects consuming ellagitannin-rich foods achieved peak plasma urolithin A levels comparable to direct supplementation at 500mg. Even with the right gut bacteria, dietary conversion is inefficient and variable. DIRECT SUPPLEMENTATION Direct urolithin A supplementation bypasses the microbiome bottleneck, providing reliable plasma levels regardless of metabotype. This is the basis of the clinical trial programme that has produced the strongest human evidence for urolithin A.
Evidence Hierarchy
Systematic Reviews & Meta-Analyses
Multiple high-quality trials combined
Randomized Controlled Trials (RCTs)
Gold standard for treatment efficacy
Observational Studies
Can show associations, not causation
Case Reports & Expert Opinion
Hypothesis-generating only
Preclinical (Lab/Animal) Studies
Should NOT be extrapolated to humans
The 5-Ingredient Formula That Targets All 12 Hallmarks of Aging
See exactly how each ingredient addresses the cellular mechanisms you just read about — backed by the same research cited on this page.
Study Quality Indicators
Higher Quality Indicators
- Large sample size (hundreds to thousands)
- Randomized and blinded design
- Placebo-controlled comparison
- Published in peer-reviewed journals
- Replicated in multiple studies
- Registered trial protocol before starting
Lower Quality Indicators
- Small sample size (under 100)
- No control group or blinding
- Manufacturer-funded with conflicts
- Only animal/cell studies
- Never replicated
- Published in predatory journals
Important Limitations
- • Supplement research often has methodological limitations
- • Results from one study may not generalize to all people
- • Marketing claims often exceed what research supports
- • Absence of evidence is not evidence of absence
- • Individual response to supplements varies widely
Quick Answers
Is urolithin A found in food?
No. Urolithin A is a postbiotic — it is produced by gut bacteria metabolising ellagitannins from foods like pomegranates, walnuts, and berries. It is not present in any food directly.
What foods lead to urolithin A production?
Pomegranates, walnuts, raspberries, strawberries, blackberries, and certain other ellagitannin-rich foods. The ellagitannins reach the colon where gut bacteria convert them.
Which gut bacteria produce urolithin A?
Specifically strains from the Gordonibacter, Ellagibacter, and Enterocloster genera. These bacteria are absent or insufficient in approximately 60% of adults.
What are urolithin metabotypes?
UM-A (40% of people) are efficient producers, UM-B (40%) produce a mix with lower conversion efficiency, and UM-0 (20%) cannot produce urolithins at all regardless of pomegranate intake.
Can I get enough urolithin A from pomegranate juice?
Only if you have the right gut bacteria. A 2021 study found only 12% of subjects had peak plasma urolithin A levels comparable to direct supplementation at 500mg when consuming ellagitannin-rich foods.
What is the pathway from ellagitannins to urolithin A?
Ellagitannins reach the colon intact, are hydrolysed to ellagic acid, then bacteria perform decarboxylation and dehydroxylation through intermediate urolithins to produce urolithin A, which is absorbed and distributed to tissues.
Why do 60% of people not produce urolithin A?
They lack sufficient populations of the specific gut bacteria (Gordonibacter, Ellagibacter, Enterocloster) required for the conversion. Diet, antibiotics, aging, and microbiome disruption all reduce these bacteria.
Does direct supplementation bypass the gut?
Yes. Direct urolithin A supplementation provides reliable plasma levels regardless of metabotype, bypassing the microbiome bottleneck entirely.
Is urolithin A the same as ellagic acid?
No. Ellagic acid is the direct hydrolysis product of ellagitannins. Urolithin A is produced by further bacterial metabolism of ellagic acid. They are different compounds with different properties.
Can probiotics help produce urolithin A?
Research is ongoing. Some probiotic strains may support the bacterial genera that produce urolithins, but reliable conversion to urolithin A from probiotics alone has not been established.
Are walnuts as good as pomegranates for urolithin A?
Both contain ellagitannins but in different amounts and profiles. Pomegranate is the most studied source. However, neither reliably produces urolithin A without the right gut bacteria.
Does cooking destroy ellagitannins?
Ellagitannins are relatively heat-stable. Cooking does not significantly destroy them, though it may alter their bioavailability and the food matrix in which they are delivered.
Is urolithin A a polyphenol?
Yes. Urolithin A is a dibenzo-b-d-pyran-6-one derivative — a microbial metabolite of ellagitannin polyphenols. It is classified as a postbiotic polyphenol.
How is urolithin A absorbed?
Urolithin A is absorbed through the colonic epithelium into the portal bloodstream, undergoes phase II conjugation (glucuronidation) in the liver, and is distributed to tissues including muscle, brain, and heart.
What is a postbiotic?
A postbiotic is a compound produced by gut bacteria as a byproduct of metabolising dietary components. Urolithin A is a postbiotic because it is not in food but is manufactured by gut bacteria from ellagitannins.
Key Research Facts
Urolithin A is a postbiotic — not found in food, but produced by gut bacteria metabolising ellagitannins from pomegranates, walnuts, and berries.
Strong EvidenceNature Metabolism — PMC8821002, 2021
Only approximately 40% of adults have the gut bacteria to efficiently convert ellagitannins to urolithin A; 60% are suboptimal or non-producers.
Strong EvidenceNature Metabolism — PMC8821002, 2021
The bacterial genera responsible are Gordonibacter, Ellagibacter, and Enterocloster — absent or insufficient in most adults.
Strong EvidenceMicrobiome research — urolithin production studies
Only 12% of subjects consuming ellagitannin-rich foods achieved plasma urolithin A levels comparable to direct 500mg supplementation.
Strong EvidenceNature Metabolism — PMC8821002, 2021
Urolithin A is absorbed through the colonic epithelium, undergoes hepatic glucuronidation, and is distributed to muscle, brain, and heart tissue.
Strong EvidencePharmacokinetic studies — urolithin A distribution
Three urolithin metabotypes (UM-A, UM-B, UM-0) determine individual capacity to produce urolithin A from dietary ellagitannins.
Strong EvidenceNature Metabolism — metabotype classification studies
Direct supplementation bypasses the microbiome bottleneck, providing reliable plasma levels regardless of metabotype.
Strong EvidenceClinical trial data — direct supplementation pharmacokinetics
Ellagitannins resist breakdown in the stomach and small intestine, reaching the colon intact where bacterial conversion occurs.
Strong EvidenceGastrointestinal biochemistry — ellagitannin metabolism
Ellagic acid is the intermediate metabolite between ellagitannins and urolithin A — they are distinct compounds with different properties.
Moderate EvidencePolyphenol metabolism research
Urolithin A received FDA GRAS status in 2020 for direct supplementation — one of the few longevity compounds to achieve this regulatory status.
Strong EvidenceFDA GRAS Notice — Amazentis/Timeline Nutrition, 2020
Citations & External Resources
JAMA Network Open — Singh et al. 2022 (Mitochondrial Health RCT)
Nature Metabolism — Urolithin Metabotypes Study (2021)
PubMed — Urolithin A Research
FDA GRAS Notice — Urolithin A (Amazentis, 2020)
Microbiome Research — Urolithin-Producing Bacteria
Pharmacokinetic Studies — Urolithin A Absorption
If You're Over 45 And Tired of Feeling Tired, Read This
Most people blame aging for their energy crash. The real culprit? Dysfunctional mitochondria. There's a science-backed solution.
Related Reading
Urolithin A: The Complete Evidence-Based Guide
Urolithin A: How It Works (Mitophagy Mechanisms)
Urolithin A Benefits: Clinical Evidence
References (3)
Written by
ReCellence™ Editorial Team
Health Content Specialists
Medically reviewed by
Medical Review Board
MD, PhD
Last updated: March 8, 2026
Last medical review: March 8, 2026